{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:48:02Z","timestamp":1793908082375,"version":"4.8.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2022,8,2]]},"abstract":"<jats:sec sec-type=\"background\" xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">Bempedoic acid (BA) inhibits ATP\u2010citrate lyase in the cholesterol synthesis pathway and lowers low\u2010density lipoprotein cholesterol (LDL\u2010C). As with other lipid\u2010lowering therapies, interindividual variation in response to BA was observed in clinical trials. We characterized LDL\u2010C response to BA using guideline\u2010defined statin intensity categories and identified clinical factors associated with enhanced LDL\u2010C lowering with BA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              This post hoc analysis used pooled data from 4 phase 3 studies. Patients were randomized 2:1 to once\u2010daily BA 180\u2009mg (n=2321) or placebo (n=1167) for 12 to 52\u2009weeks and grouped based on percent change in LDL\u2010C from baseline to week 12 according to guideline\u2010established statin intensity categories. Factors associated with \u226530% reduction in LDL\u2010C were identified using logistic regression analyses. From baseline to week 12, BA lowered LDL\u2010C levels comparable to a moderate\u2010 or high\u2010intensity statin (\u226530%) in 28.9% of patients; this degree of LDL\u2010C lowering was observed in 50.9% of patients not receiving background statin therapy. In a multivariable analysis, the absence of statins, female sex, a history of diabetes, ezetimibe use, and higher high\u2010sensitivity C\u2010reactive protein level were associated with increased rates of achieving \u226530% LDL\u2010C reduction with BA (\n              <jats:italic>P<\/jats:italic>\n              &lt;0.01 for each).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">A large percentage of patients receiving BA achieved LDL\u2010C reductions comparable to a moderate\u2010 or high\u2010intensity statin. Factors including statin absence, female sex, diabetes history, ezetimibe use, and a higher high\u2010sensitivity C\u2010reactive protein level may be useful to identify patients who may have a greater LDL\u2010C reduction with BA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Registration<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              URL:\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n              ; Unique identifiers: NCT02666664, NCT02991118, NCT02988115, NCT03001076.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.121.024531","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T11:40:26Z","timestamp":1659440426000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Factors Associated With Enhanced Low\u2010Density Lipoprotein Cholesterol Lowering With Bempedoic Acid"],"prefix":"10.1161","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-1730","authenticated-orcid":false,"given":"Christie M.","family":"Ballantyne","sequence":"first","affiliation":[{"name":"Department of Medicine Baylor College of Medicine Houston TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold E.","family":"Bays","sequence":"additional","affiliation":[{"name":"Louisville Metabolic and Atherosclerosis Research Center Louisville KY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Louie","sequence":"additional","affiliation":[{"name":"Esperion Therapeutics, Inc. Ann Arbor MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Smart","sequence":"additional","affiliation":[{"name":"Esperion Therapeutics, Inc. Ann Arbor MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Esperion Therapeutics, Inc. Ann Arbor MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-060X","authenticated-orcid":false,"given":"Kausik K.","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Public Health Imperial College London London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.615"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvw006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.2314"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"},{"key":"e_1_3_2_6_2","first-page":"e106","article-title":"LDL cholesterol response and statin adherence among high\u2010risk patients initiating treatment","volume":"22","author":"Vupputuri S","year":"2016","unstructured":"Vupputuri S, Joski PJ, Kilpatrick R, Woolley JM, Robinson BE, Farkouh ME, Yun H, Safford MM, Muntner P. LDL cholesterol response and statin adherence among high\u2010risk patients initiating treatment. Am J Manag Care. 2016;22:e106\u2013e115.","journal-title":"Am J Manag Care"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.4158\/CS-2020-0490"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.03.004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2013.03.007"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.000851"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.005562"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.03.032"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-019-1107-y"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-7-200910060-00009"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-018-6784-z"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1994-9"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.121.024531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:15:36Z","timestamp":1715598936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.121.024531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":15,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,8,2]]}},"alternative-id":["10.1161\/JAHA.121.024531"],"URL":"https:\/\/doi.org\/10.1161\/jaha.121.024531","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"2021-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e024531"}}